Autolus Therapeutics (AUTL) Assets: 2017-2025
Historic Assets for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $661.9 million.
- Autolus Therapeutics' Assets fell 20.01% to $661.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $661.9 million, marking a year-over-year decrease of 20.01%. This contributed to the annual value of $782.7 million for FY2024, which is 108.51% up from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Assets is $661.9 million, which was down 8.19% from $721.0 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Assets high stood at $901.4 million for Q1 2024, and its period low was $263.8 million during Q3 2022.
- Its 3-year average for Assets is $653.4 million, with a median of $721.0 million in 2025.
- Per our database at Business Quant, Autolus Therapeutics' Assets decreased by 23.43% in 2023 and then soared by 108.51% in 2024.
- Quarterly analysis of 5 years shows Autolus Therapeutics' Assets stood at $405.6 million in 2021, then climbed by 20.89% to $490.3 million in 2022, then fell by 23.43% to $375.4 million in 2023, then skyrocketed by 108.51% to $782.7 million in 2024, then declined by 20.01% to $661.9 million in 2025.
- Its last three reported values are $661.9 million in Q3 2025, $721.0 million for Q2 2025, and $746.3 million during Q1 2025.